Financial results - TRANSYLVANIA PHARMACEUTICALS SRL

Financial Summary - Transylvania Pharmaceuticals Srl
Unique identification code: 31383364
Registration number: J35/1358/2015
Nace: 4941
Sales - Ron
-
Net Profit - Ron
0
Employee
The most important financial indicators for the company Transylvania Pharmaceuticals Srl - Unique Identification Number 31383364: sales in 2023 was - euro, registering a net profit of 0 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Transporturi rutiere de marfuri having the NACE code 4941.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Transylvania Pharmaceuticals Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 5.741.724 33.579 6.881 0 0 0 0 0 0 0
Total Income - EUR 5.742.991 34.387 8.354 107 7.952 39 34 23 32 7
Total Expenses - EUR 5.706.940 35.821 5.553 95 1.343 262 4 3 275 7
Gross Profit/Loss - EUR 36.050 -1.434 2.801 12 6.609 -223 30 20 -244 0
Net Profit/Loss - EUR 29.545 -1.434 2.557 11 6.372 -224 29 19 -244 0
Employees 3 2 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.

Check the financial reports for the company - Transylvania Pharmaceuticals Srl

Rating financiar

Financial Rating -
Transylvania Pharmaceuticals Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Transylvania Pharmaceuticals Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Transylvania Pharmaceuticals Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Transylvania Pharmaceuticals Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Transylvania Pharmaceuticals Srl - CUI 31383364

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 25.610 20.063 0 0 0 0 0 0 0 0
Current Assets 71.569 69.686 64.094 60.375 52.405 51.167 50.227 49.133 49.042 48.894
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 44.270 66.339 57.557 53.916 46.064 45.172 50.227 49.133 49.042 48.894
Cash 27.299 3.347 6.537 6.458 6.341 5.995 0 0 0 0
Shareholders Funds 44.075 43.009 45.128 44.375 49.933 48.742 47.847 46.805 46.706 46.565
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 53.365 46.766 18.966 15.999 2.473 2.426 2.380 2.328 2.335 2.328
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4941 - 4941"
CAEN Financial Year 4941
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 48.894 euro in 2023 which includes Inventories of 0 euro, Receivables of 48.894 euro and cash availability of 0 euro.
The company's Equity was valued at 46.565 euro, while total Liabilities amounted to 2.328 euro. Equity increased by 0 euro, from 46.706 euro in 2022, to 46.565 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Transylvania Pharmaceuticals Srl

Comments - Transylvania Pharmaceuticals Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.